ASH Annual Conference 2025 Dec 6 - Dec 9, 2025 Poster Title: Poster 1652: ENLIGHT-AML: A Phase 1 Study of GB3226, a Novel Dual Inhibitor of ENL-YEATS and FLT3, in Patients with Relapsed / Refractory Acute Myeloid LeukemiaPoster Title: Poster 6106: GB3226, a Novel, Orally Active, First-in-Class, Small Molecule Dual Inhibitor of ENL-YEATS and FLT3 Kinase for the Treatment of Relapsed/Refractory Acute Myeloid Leukemiahttps://www.hematology.org/meetings/annual-meeting
